CivicaScript to distribute biosimilar for chronic inflammatory conditions

Mallinckrodt and Endo complete merger

Zenara Pharma's Sertraline Hydrochloride Capsules generic receives US FDA approval

EQT agrees to acquire majority stake in Adalvo

Mallinckrodt receives Irish High Court ruling to combine with Endo Inc

Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications

CivicaScript introduces low-cost multiple sclerosis treatment

Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval

Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)

AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment

Avera joins Civica to help maintain drug supplies

Apotex launches generic version of Tasigna in US market

CivicaScript launches droxidopa for symptomatic neurogenic orthostatic hypotension

Padagis' Naloxone HCl Nasal Spray 4 mg obtains extended shelf-life of 36 months

ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets